Mario Legault

Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir

C. Tremblay, B. Brenner, D. Rouleau, 2018, Retrovirology.

High rates of forward transmission events after acute/early HIV-1 infection.

Michel Roger, M. Wainberg, C. Tremblay, 2007, The Journal of infectious diseases.

Performance of Bio-Rad and Limiting Antigen Avidity Assays in Detecting Recent HIV Infections Using the Quebec Primary HIV-1 Infection Cohort

C. Tremblay, J. Routy, D. Hamel, 2016, PLoS ONE.